Skip to main content

Want a detailed portfolio tracker?

Coeptis Therapeutics Holdings Inc. Common Stock (COEP) P/E (2021 - 2022)

Coeptis Therapeutics Holdings Inc. Common Stock (COEP) P/E from Mar 31, 2021 to Oct 28, 2022. The TTM Coeptis Therapeutics Holdings Inc. Common Stock (COEP) P/E is 4.33. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Coeptis Therapeutics Holdings Inc. Common Stock (COEP)

YearP/EChange
20224.33+488.15%
20210.74N/A

Comparison Coeptis Therapeutics Holdings Inc. Common Stock (COEP) P/E with competitors

Coeptis Therapeutics Holdings Inc. Common Stock (COEP) P/E is 4.33.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.96%
NBYStablecoin Development Corp0.00-99.90%
ENLVEnlivex Ltd0.07-98.27%
FGENFibroGen Inc0.24-94.46%
CHRSCoherus Biosciences Inc0.85-80.41%
FBIOFortress Biotech Inc0.95-78.09%
ORMPOramed Pharmaceuticals Inc1.50-65.30%
AGENAgenus Inc3.01-30.53%
INVAInnoviva Inc3.15-27.19%
VXRTVaxart Inc3.55-18.06%
CRMDCorMedix Inc3.63-16.24%
CVACCureVac N.V.4.45+2.62%
GLPGGalapagos NV4.86+12.16%
SRPTSarepta Therapeutics Inc4.88+12.70%
ABEOAbeona Therapeutics Inc5.39+24.36%
ABUSArbutus Biopharma Corp5.60+29.17%
ZVRAZevra Therapeutics Inc5.89+35.90%
SPROSpero Therapeutics Inc6.23+43.78%
CGENCompugen Ltd6.31+45.75%
RIGLRigel Pharmaceuticals6.87+58.63%
SLXNSilexion Therapeutics Corp7.30+68.42%
OMEROmeros Corporation9.26+113.73%
AUPHAurinia Pharmaceuticals Inc9.58+121.26%
PLXProtalix BioTherapeutics Inc10.89+151.40%
ACADAcadia Pharmaceuticals Inc11.73+170.74%
TBPHTheravance Biopharma Inc12.26+183.06%
ADMAAdma Biologics Inc12.42+186.66%
HRMYHarmony Biosciences Holdings Inc13.82+219.02%
SABSSAB Biotherapeutics Inc14.14+226.32%
NAGENiagen Bioscience Inc14.82+242.06%
INCYIncyte Corp15.82+265.24%
REGNRegeneron Pharmaceuticals Inc15.86+266.03%
PBYIPuma Biotechnology Inc17.32+299.71%
CPRXCatalyst Pharmaceuticals Inc17.44+302.57%
EXELExelixis Inc17.54+304.84%
TGTXTG Therapeutics Inc18.97+337.81%
MDXGMimedx Group Inc20.55+374.43%
XOMAXOMA Royalty Corp22.87+428.05%
ARGXArgen X SE24.30+460.90%
CTMXCytomX Therapeutics Inc24.82+472.98%
XOMAOXOMA Royalty Corp25.34+485.07%
HALOHalozyme Therapeutics Inc25.62+491.51%
XOMAPXOMA Royalty Corp25.67+492.58%
VRTXVertex Pharmaceuticals Inc27.99+546.24%
RPRXRoyalty Pharma plc - Class A28.69+562.23%
SLNOSoleno Therapeutics Inc29.02+569.80%
ASNDAscendis Pharma A/S30.09+594.51%
LGNDLigand Pharmaceuticals Inc - Class B37.91+775.18%
APLSApellis Pharmaceuticals Inc39.02+800.78%
BMRNBiomarin Pharmaceutical Inc42.21+874.43%
KRYSKrystal Biotech Inc45.34+946.73%
ONCBeiGene Ltd69.54+1505.30%
PHARPharming Group N.V.75.03+1631.92%
TECHBio-Techne Corp101.96+2253.65%
VCELVericel Corp109.92+2437.47%
ALNYAlnylam Pharmaceuticals Inc117.96+2623.15%
GMABGenmab140.29+3138.53%
TLXTelix Pharmaceuticals Ltd162.15+3643.20%
CORTCorcept Therapeutics Inc212.86+4813.69%